Analysis of neutropenia as a predictive factor of the efficacy of trifluridine-tipiracil treatment
Int. Journal of Clinical Pharmacology and Therapeutics · 2023
DOI: 10.5414/cp204410 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2023. Verfasst von Loreto Domínguez Senín und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antineoplastic Agents, Colonic Neoplasms, Colorectal Neoplasms, Neutropenia. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Domínguez Senín, L., Rodriguez Garcés, M. Y., Aviñó Tarazona, V., Amor Urbano, M., Santos-Rubio, M. D., & Bayo Calero, J. (2023). Analysis of neutropenia as a predictive factor of the efficacy of trifluridine-tipiracil treatment. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204410
Vancouver
Domínguez Senín L, Rodriguez Garcés MY, Aviñó Tarazona V, Amor Urbano M, Santos-Rubio MD, Bayo Calero J. Analysis of neutropenia as a predictive factor of the efficacy of trifluridine-tipiracil treatment. Int. Journal of Clinical Pharmacology and Therapeutics. 2023. doi:10.5414/cp204410
BibTeX
@article{DomnguezSenn2023,
author = {Domínguez Senín, Loreto and Rodriguez Garcés, María Yeray and Aviñó Tarazona, Victoria and Amor Urbano, María and Santos-Rubio, Maria Dolores and Bayo Calero, Juan},
title = {Analysis of neutropenia as a predictive factor of the efficacy of trifluridine-tipiracil treatment},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2023},
doi = {10.5414/cp204410}
}
EUVIMED